Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)

Latest Ratings for AGIO

Date Firm Action From To
Mar 2022 Goldman Sachs Maintains Sell
Mar 2022 HC Wainwright & Co. Maintains Buy
Feb 2022 RBC Capital Maintains Outperform

View More Analyst Ratings for AGIO

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *